Get the StoQuant digest — free
Daily Q-Score changes, insider buy clusters, and ML forecast updates for the tickers you follow.
Email only, no account needed. See a sample digest.
FMS vs GMAB — Stock Comparison
Compare FMS and GMAB side-by-side on StoQuant: Q-Scores, alt data signals, insider buying, catalysts, strategic edges, short interest, social sentiment, and macro context.
Side-by-side snapshot
- FMS — Fresenius Medical Care AG & Co. KGaA · Health Care · market cap $12.64B · Q-Score verdict Sell (44.0, grade D). Full FMS research.
- GMAB — Genmab A/S · Health Care · market cap $20.27B · Q-Score verdict Buy (55.0, grade B). Full GMAB research.
What you can compare
- Q-Score: StoQuant's composite 0–100 rating based on 140+ financial signals.
- Alt data signals: Google Trends, EDGAR 8-K filings, job postings, and more.
- Insider activity: Cluster scores and recent Form 4 buying.
- Catalysts: Earnings, analyst changes, M&A, clinical trials, and SEC events.
- Strategic edges: Competitive moat and durable advantage analysis.
- Short interest & social sentiment: Short % float, social mention volume, and bullish/bearish breakdown.
- Macro context: Market regime and sector rotation alignment.
Deep dive: FMS research · GMAB research. Sign in to StoQuant to run live comparisons for any tickers.